Treatment Guidelines from The Medical Letter
Antiviral Drugs
The full article is available to subscribers Subscriber Login   
Revised 2/6/15: A sentence about the discontinuation of boceprevir and telaprevir has been added to that paragraph, and to footnote 7 in Table 5.

The drugs of choice for treatment of viral infections (other than HIV) and their dosages are listed in Tables 1-6 on the pages that follow. Some of the indications and dosages recommended here have not been approved by the FDA. Vaccines used for the prevention of viral infections are discussed elsewhere.1


ACYCLOVIR — Available in topical, oral and IV formulations, acyclovir (Zovirax, and generics) is used to treat and suppress varicella-zoster virus (VZV) and herpes simplex virus (HSV) infections.

Oral acyclovir begun within 24 hours of rash onset decreases the severity of primary VZV infection (chicken pox). It can also reduce pain and the risk of post-herpetic neuralgia in patients with localized zoster if taken within 48-72 hours after the onset of rash. Suppression with oral acyclovir ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Antiviral Drugs
Article code: 127a
 Electronic, downloadable article - $25